![](/img/cover-not-exists.png)
Efficacy and safety of the combination of metformin, everolimus and exemestane in overweight and obese postmenopausal patients with metastatic, hormone receptor-positive, HER2-negative breast cancer: a phase II study
Yam, Clinton, Esteva, Francisco J., Patel, Miral M., Raghavendra, Akshara S., Ueno, Naoto T., Moulder, Stacy L., Hess, Kenneth R., Shroff, Girish S., Hodge, Silvia, Koenig, Kimberly H., Chavez Mac GreLanguage:
english
Journal:
Investigational New Drugs
DOI:
10.1007/s10637-018-0700-z
Date:
January, 2019
File:
PDF, 499 KB
english, 2019